Thomas Flaig, MD, vice chancellor of research for CU Denver and CU Cancer Center member, discusses some of the current NCCN guidelines in bladder cancer.
CU Anschutz
Anschutz Cancer Pavilion
1665 North Aurora Court
2004
Aurora, CO 80045
Flaig Discusses NCCN Guidelines in Bladder Cancer
by Targeted Oncology | January 24, 2023
